Gamma-hydroxybutyric acid: Efficacy, potential abuse, and dependence in the treatment of alcohol addiction

Alcohol

Volumn 20, Issue 3, 2000, Pages 217-222

  Addolorato, Giovanni ^a,b   Caputo, Fabio ^b   Capristo, Esmeralda ^a   Stefanini, G Francesco ^c   Gasbarrini, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c Ospedale di Faenza   (Italy)

Author keywords

Abuse; Alcoholism; Clinical use; Dependence; Efficacy; Gamma hydroxybutyric acid; Illicit use; Side effects; Withdrawal

Indexed keywords

4 HYDROXYBUTYRIC ACID;

ABSTINENCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG DEPENDENCE; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; NONHUMAN; PSYCHOLOGICAL ASPECT; RELAPSE; SOCIAL ASPECT;

ALCOHOLISM; HUMANS; HYDROXYBUTYRATES; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 0034046688     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-8329(99)00084-1     Document Type: Conference Paper

References (53)

1. Addolorato G., Stefanini G.F., Casella G., Marsigli L., Caputo F., Gasbarrini G. Evaluation of the therapeutic efficacy of gamma-hydroxybutyric acid in the medium-term treatment of alcoholic outpatients. preliminary data from an open multicentric study Alcologia Eur J Alcohol Stud. 7:1995;233-236.
2. Addolorato G., Castelli E., Stefanini G.F., Casella G., Caputo F., Marsigli L., Bernardi M., Gasbarrini G. An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. Alcohol Alcohol. 31:1996;341-345.
3. Addolorato G., Stefanini G.F., Gasbarrini G. Manageability and tolerability of gamma-hydroxybutyric acid in the medium-term outpatient treatment of alcoholism. Alcohol Clin Exp Res. 21:1997;380. a.
4. Addolorato G., Caputo F., Stefanini G.F., Gasbarrini G. Gamma-hydroxybutyric acid in the treatment of alcohol dependence. possible craving development for the drug Addiction. 92:1997;1041-1042. b.
5. Addolorato G., Cibin M., Capristo E., Beghé F., Gessa G.L., Stefanini G.F., Gasbarrini G. Maintaining abstinence from alcohol by gamma-hydroxybutyric acid. Lancet. 351:1998;38. a.
6. Addolorato G., Stefanini G.F., Gasbarrini G. Patients with alcohol problem. N Engl J Med. 339:1998;130. b.
7. Addolorato G., Cibin M., Caputo F., Capristo E., Gessa G.L., Stefanini G.F., Gasbarrini G. Gamma-hydroxybutyric acid in the treatment of alcoholism. dosage fractioning utility in non-responder alcoholic patients Drug Alcohol Depend. 53:1998;7-10. c.
8. Addolorato G., Caputo F., Capristo E., Bernardi M., Stefanini G.F., Gasbarrini G. A case of gamma-hydroxybutyric acid withdrawal syndrome during alcohol addiction treatment. utility of diazepam administration Clin Neuropharmacol. 22:1999;60-62. a.
9. Addolorato G., Capristo E., Gessa G.L., Caputo F., Stefanini G.F., Gasbarrini G. Long-term administration of GHB does not affect muscular mass in alcoholics. Life Sci. 65:1999;PL191-PL196. b.
10. Agabio R., Colombo G., Loche A., Lobina C., Pani L., Reali R., Gessa G.L. Gamma-hydroxybutyric acid reducing effect on ethanol intake. evidence in favour of a substitution mechanism Alcohol Alcohol. 33:1998;1-10.
11. Anden N., Magnusson T., Stock G. Effects of drugs influencing monoamine mechanisms on the increase in brain dopamine produced by axotomy or treatment with gamma-hydroxybutyric acid. Arch Pharmacol. 278:1973;363-368.
12. Anonymous GHB follows ketamine as UK rave scene embraces downer drugs. Druglink. 9:1994;5.
13. Carter J., Mofenson H., Carraccio T., Smith P., Morse D., Keys C., Williams L., Coody G. Gamma-hydroxybutyrate use. New York and Texas, 1995-1996 Morb Mortal Wkly Rep. 46:1997;281-283.
14. Chin M.Y., Kreutzer R.A., Dyer J.B. Acute poisoning from gamma-hydroxybutyrate in California. West J Med. 156:1992;380-384.
15. Colombo G., Agabio R., Lobina C., Reali R., Fadda F., Gessa G.L. Symmetrical generalization between the discriminative stimulus effects of gamma-hydroxybutyric acid and ethanol. occurrence within narrow dose ranges Physiol Behav. 57:1995;105-111. a.
16. Colombo G., Agabio R., Lobina C., Reali R., Fadda F., Gessa G.L. Cross tolerance to ethanol and gamma-hydroxybutyric acid. Eur J Pharmacol. 273:1995;235-238. b.
17. Colombo G., Agabio R., Diaz G., Fà M., Lobina C., Reali R., Gessa G.L. Gamma-hydroxybutyric acid (GHB) intake in ethanol-preferring sP and -non preferring sNP rats. Physiol Behav. 64:1998;197-202.
18. Dall'Aglio C., Caputo F., Baudanza P., Castelli E., Marsigli L., Moscatello M., Addolorato G., Stefanini G.F. Short and long-term treatment of alcohol dependence. Alcologia Eur J Alcohol Stud. 9:1997;61-64.
19. Di Bello M.G., Gambassi F., Mugnai L., Masini E., Mannaioni P.F. Gamma-hydroxybutyric acid induced suppression and prevention of alcohol withdrawal syndrome and relief of craving in alcohol dependent patients. Alcologia Eur J Alcohol Stud. 7:1995;9-16.
20. Dyer J. Gamma-hydroxybutyrate. a health food product producing coma and seizure-like activity Am J Emerg Med. 9:1991;321-324.
21. Dyer J., Kreutzer R.A., Quattrone A. Multistate outbreak of poisonings associated with illicit use of gamma-hydroxybutyrate. Morb Mortal Wkly Rep. 39:1990;861-863.
22. Edwards A.G.K., Rollnick S. Outcome studies of brief alcohol intervention in general practice. the problem of lost subjects Addiction. 92:1997;1699-1704.
23. Erickson C.K. Review of neurotransmitters and their role in alcoholism treatment. Alcohol Alcohol. 31(suppl. 1):1996;5-11.
24. Erickson, C. K., & O' Neill, J. T. (1995). It is time. National Council on Alcoholism and Drug Dependence Amethyst 3, Summer (pp. 1-2). New York: National Council on Alcoholism and Drug Dependence.
25. Ferrara S.D., Zotti S., Tedeschi L., Frison G., Castagna F., Gallimberti L., Gessa G.L., Palatini P. Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. Br J Clin Pharmacol. 34:1992;231-235.
26. Friedman J., Westlake R., Furman M. "Grievous bodily harm" gamma-hydroxybutyrate abuse leading to a Wernicke-Korsakoff syndrome Neurology. 46:1996;460-471.
27. Gallimberti L., Canton G., Gentile N., Cibin M., Ferri M., Ferrara S.D., Fadda F., Gessa G.L. Gamma-hydroxybutyric acid for the treatment of alcohol withdrawal syndrome. Lancet. 2:1989;787-789.
28. Gallimberti L., Ferri M., Ferrara S.D., Fadda F., Gessa G.L. Gamma-hydroxybutyric acid in the treatment of alcohol dependence. a double blind study Alcohol Clin Exp Res. 16:1992;673-676.
29. Galloway G.P., Frederick S.L., Staggers F.E. Physical dependence on sodium oxybate. Lancet. 342:1994;57.
30. Galloway G.P., Frederick S.L., Staggers F.E., Gonzales M., Stalcup S.A., Smith D.E. Gamma-hydroxybutyrate. an emerging drug of abuse that causes physical dependence Addiction. 92:1997;89-96.
31. Gerra G., Marcato A., Fertonani Affini G., Avanzini P., Lechini R., Maestri D., Fontanesi B., Caccavari R., Delsignore R. Gamma-hydroxybutyric acid (GHB) and neuroendocrine function in human. Neuroendocrinol Lett. 16:1994;55-63.
32. Gessa G.L., Crabai F., Vargiu L., Spano P.F. Selective increase of brain dopamine induced by gamma-hydroxybutyrate. study of the mechanism of action J Neurochem. 15:1968;377-381.
33. Gessa G.L., Agabio R., Carai M.A.M., Lobina C., Pani M., Reali R., Colombo G. Mechanism of the antialcohol effect of gamma-hydroxybutyric acid. Alcohol. 20:2000;271-276.
34. Gianoulakis C. Implication of endogenous opioids and dopamine in alcoholism. human and basic science studies Alcohol Alcohol. 31(suppl. 1):1996;33-42.
35. Kranzler H.R., Anton R.F. Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism. J Consult Clin Psychol. 62:1994;1116-1126.
36. Li J., Stokes S.A., Woeckener A. A tale of novel intoxication. seven cases of gamma-hydroxybutyric acid overdose Ann Emerg Med. 31:1998;723-728.
37. Louagie H.K., Verstraete A.G., De Soete C.J., Baetens D.G., Calle P. A sudden awakening from a near coma after combined intake of gamma-hydroxybutyric acid (GHB) and ethanol. J Toxicol Clin Toxicol. 35:1997;591-594.
38. Luby S., Jones J., Zalewski A. GHB use in South Carolina. Am J Pub Health. 82:1992;128.
39. Marwick C. Coma inducing drug GHB may be reclassified. J Am Med Assoc. 277:1997;1505-1506.
40. Meldrum B. GABA-agonist as anti-epileptic agent. Adv Biochem Psychopharmacol. 26:1981;207-217.
41. O'Connor P.G., Schottenfeld R.S. Patients with alcohol problem. N Engl J Med. 338:1998;592-602.
42. Poldrugo F., Addolorato G. The role of gamma-hydroxybutyric acid (GHB) in the treatment of alcoholism. from animal to clinical studies Alcohol Alcohol. 34:1999;15-24.
43. Roth R.H., Doherty J.D., Walters J.R. Gamma-hydroxybutyrate. a role in the regulation of central dopaminergic neurons Brain Res. 189:1980;556-560.
44. Shapiro, H. (1994). Information for drug workers. Factsheet No. 8, GHB. London Institute for the study of drug dependence.
45. Snead O.C., Bearden L.J. Naloxone overcomes the dopaminergic, EEG, and behavioral effects of gamma-hydroxybutyrate. Neurology. 30:1980;832-838.
46. Snead O.C., Moreley B.J. Ontogeny of gamma-hydroxybutyric acid. regional concentration in developing rat, monkey and human brain Brain Res. 227:1981;579-589.
47. Spano P.F., Przegalinski E. Stimulation of serotonin synthesis by anaesthetic and nonanaesthetic doses of gamma-hydroxybutyrate. Pharmacol Res Commun. 5:1973;55-69.
48. Takahara J., Yunoki S., Yakushji W., Yamauchi J., Yamane Y., Ofuji T. Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans. J Clin Endocrinol Metab. 44:1977;1014-1017.
49. Thomas G., Bonner S., Gascoigne A. Coma induced by abuse of gamma-hydroxybutyrate (GHB or liquid ecstasy). a case report Br Med J. 314:1997;35-36.
50. Tunnicliff G. Site of action of gamma-hydroxybutyrate (GHB). a neuroactive drug with abuse potential J Toxicol Clin Toxicol. 35:1997;581-590.
51. Warning about GHB. J Am Med Assoc. 265:1991;1802.
52. Vayer P., Mandel M., Maitre M. Gamma-hydroxybutyrate, a possible neurotransmitter. Life Sci. 41:1987;1547-1557.
53. Zolesi O., Daini L., Capone M.R., Aglietti M., Raimondi F., Maremmani I. The use of GHB in anticraving therapy. preliminary experimental data of its use in alcohol and heroin dependence Tagliamonte A., Maremmani I. Drug Addiction and Related Clinical Problems. 1994;57-62 Springer-Verlag, Wien, New York.